2,866 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 212 funds opening new positions, 1,179 increasing their positions, 1,238 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

5% less repeat investments, than reductions

Existing positions increased: 1,179 | Existing positions reduced: 1,238

1.16% less ownership

Funds ownership: 67.15%65.99% (-1.2%)

40% less call options, than puts

Call options by funds: $2.36B | Put options by funds: $3.9B

Holders
2,866
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
33
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.36B
Puts
$3.9B
Net Calls
Net Calls Change

Top Buyers

1 +$346M
2 +$334M
3 +$233M
4
Citadel Advisors
Citadel Advisors
Florida
+$217M
5
Norges Bank
Norges Bank
Norway
+$199M
Name Holding Trade Value Shares
Change
Change in
Stake
551
$7.17M
552
$7.16M
553
$7.05M
554
$7.02M
555
$7.01M
556
$6.99M
557
$6.96M
558
$6.95M
559
$6.92M
560
$6.91M
561
$6.85M
562
$6.8M
563
$6.79M
564
$6.76M
565
$6.75M
566
$6.74M
567
$6.73M
568
$6.71M
569
$6.69M
570
$6.69M
571
$6.66M
572
$6.64M
573
$6.63M
574
$6.61M
575
$6.59M